Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models

Tamara Terzian1, Melissa Dumble, Farinaz Arbab

  • 1Department of Dermatology, UC Denver, Aurora, CO, USA.

Insights

A mutation in the ribosomal protein Rpl27a gene causes p53 pathway defects, leading to ataxia and pancytopenia in mice. This highlights Rpl27a

Area of Science:

  • Molecular Biology
  • Genetics
  • Developmental Biology

Background:

  • Ribosomal stress is a poorly understood activator of the p53 tumor suppressor.
  • The p53 pathway is critical for preventing cancer and maintaining genomic stability.

Purpose of the Study:

  • To investigate the role of ribosomal protein Rpl27a in p53 pathway activation and its impact on development and tumorigenesis.
  • To identify novel genetic mutations affecting the p53 pathway.

Main Methods:

  • Utilized N-ethyl-N-nitrosourea (ENU) mutagenesis screen to identify mutations affecting the p53 pathway.
  • Phenotypic analysis of mutant mice, including neurological, hematological, and epidermal assessments.
  • Genetic analysis, including rescue experiments in a p53 haploinsufficient background.
  • Detailed examination of bone marrow to assess hematopoietic stem cells and gene expression.

Main Results:

  • Identified a mutation in the Rpl27a gene (sooty foot ataxia mice) causing p53 pathway defects.
  • Mutant mice exhibited phenotypes mimicking high p53 models: cerebellar ataxia, pancytopenia, and epidermal hyperpigmentation.
  • Phenotypes were rescued in a p53 haploinsufficient background, confirming p53 dependency.
  • Observed reduced hematopoietic stem cells and p53-dependent c-Kit downregulation in bone marrow.
  • Mutant mice showed a delay in tumorigenesis, indicating increased p53 activity.

Conclusions:

  • Rpl27a plays a crucial role in multiple tissues, influencing both development and transformation.
  • Disruption of Rpl27a leads to increased p53 activity in vivo.
  • Ribosomal protein dysfunction is a significant factor in p53-mediated tumor suppression.